Comparison of insulin lispro low mixture with insulin glargine when initiating and intensifying insulin therapy as required in patients with type 2 diabetes who have inadequate glycemic control on oral antihyperglycemic medication.
Phase of Trial: Phase IV
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PARADIGM
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 13 Jun 2017 Results of post hoc analysis evaluating glycemic profiles of lispro Mix25-treated patients, presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 05 Jun 2012 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met according to results published in Diabetic Medicine.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History